Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2003-08-25
2008-12-02
Stucker, Jeffrey (Department: 1649)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S141100, C530S387100, C530S388100, C530S389100
Reexamination Certificate
active
07459156
ABSTRACT:
The use and production of immunoglobulins which activate trk receptors and imitate effects of neurotrophins are provided. Immunoglobulins which block trk receptor activation and methods of use are also provided.
REFERENCES:
patent: 5231001 (1993-07-01), Kaplan et al.
patent: 5753225 (1998-05-01), Clary et al.
patent: 5877305 (1999-03-01), Huston et al.
patent: 0471205 (1992-02-01), None
patent: 92/16559 (1992-10-01), None
patent: WO 92/18149 (1992-10-01), None
Olson,Exp. Neurol., vol. 124, pp. 5-15, 1993.
Olson,Acta Neurochir, vol. 58 [Suppl.], pp. 3-7, 1993.
Tuszynski et al.Am. Neurol., vol. 35, pp. S9-S12, 1994.
Rich et al.Neuroendo., vol. 16, pp. 261-265, 1986.
Alberts, et al. “Molecular Biology of the Cell”Garland Publishing Inc. (N.Y) (1989), pp. 333-334.
Barde, Y.A., “Tropic Factors and Neuronal Survival”Neuron. (1989) vol. 2, pp. 1525-1534.
Barker, et al. “The Nerve Growth Factor Receptor: A Mulitcomponent System that Mediates the Actions of the Neurotrophin Family of Proteins”Molecular and Cellular Biochemistry(1992) vol. 110, p. 1-15.
Bolhuis, et al. “Functional Expression of a Single Chain FV/γ Receptor with Renal Cell Carinoma Specificity in Activated Human PBL”Third Meeting of the European Working Group of Human Gene Transfer and Therapy,Barcelona, Spain (Nov. 17-20, 1995)Gene Therapy 2(Suppl. 1):S21 ISSN: 0969-7128.
Bolhuis, et al. “ScFv/gamma Antibody Receptors on Human Cytotoxic T Lymphocytes (CTL) Bind Antigen, Transduce Activation Signals and Respond to Co-regulatory Signals” Joint Meeting of the American Academy of Allergy, Asthma and Immunology, the American Association of Immunologists and the Clinical Immunology Society San Francisco, California, USA (Feb. 21-26, 1997)J. Allergy Clin Immunol 99(1,Pt2):S116, 1997 ISSN:0091-6749.
Casten, et al. “Anti-immunoglobulin Augments the B-Cell Antigen-presentation Function Independently of Internalization of Receptor-Antigen Complex”Proc. Natl. Acad. Sci. USA(Sep. 1985) vol. 82, pp. 5890-5894.
Collazo, et al. “Celluar Targets and Trophic Functions of Neurotrophin-3 in the Developing Rat Hippocampus”Neuron(Oct. 1992) vol. 9, pp. 643-656.
Cordon-Cardo, et al. “ThetrkTyrosine Protein Kinase Mediates the Mitogenic Properties of Nerve Growth Factor and Neurotrophin-3”Cell(1991) vol. 66, pp. 173-183.
Drebin, et al. “Down-Modulation of an Oncogene Protein Product and Reversion of the Transformed Phenotype by Monoclonal Antibodies”Cell(Jul. 1985) vol. 41, pp. 695-706.
Eager, K. “Molecular Characterization of HumantrkProto-oncogene product Monoclonal Antibodies”Onc. (May 1991) vol. 6(5), pp. 819-824.
Eide, et al. “Neurotrophins and Their Receptors-Current Concepts and Implications for Neurologic Disease”Exp. Neurol.(1993) vol. 121, pp. 200-214.
Fan, et al. “Regulation of Epidermal Growth Factor Receptor in NIH3T3/HER14 Cells by Antireceptor Monoclonal Antibodies”J. of Biological Chemistry(Oct. 1993) vol. 268 (28), pp. 21073-21079.
Fraser, et al. “TCP-11, the Product of a Mouset-complex Gene, Plays a Role in Stimulation of Capacitation and Inhibition of the Spontaneous Acrosome Reaction”Molocular Reproduction and Development(1997), vol. 48, pp. 375-382.
Greene, et al. “Establishment of a Noradrenergic Clonal Line of Rat Adrenal Pheochromocytoma Cells Which Respond to Nerve Growth Factor”Proc. Natl. Acad. Sci. USA(1976) vol. 73, pp. 2424-2428.
Goroff, et al. “Participation of IgGFe Receptor (FeγR) in in vivo B-cell Activation by a Monovalent Anti-IgD Antibody (Ab) Fragment”Fed Proc(1987) vol. 46(4), pp. 1204.
Hanks, et al. “The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains”Science(1988) vol. 241, pp. 42-52.
Holzer, et al. “A Fusion Protein of IL-8 and a Fab Antibody Fragment Binds to IL-8 Receptors and Induces Neutrophil Activation”Cytokine(Mar. 1996) vol. 8(3), pp. 214-221.
Holtzman, et al. “p 140trkmRNA Marks NGF-Responsive Forebrain Neurons: Evidence thattrkGene Expression is Induced by NGF”Neuron(1992) vol. 9, pp. 465-478.
Hosang, et al. “Molecular Characteristics of Nerve Growth Factor Receptors on PC12 Cells”J. Biol. Chem. (1985) vol. 260, pp. 655-662.
Hutton, et al. “Expression of p75NGFRTrkA and TrkB, mRNA in Rat C6 Glioma and Type I Astrocyte Cultures”J. of Neurosciences Research(1992), vol. 32, pp. 375-383.
Jing, et al. “Nerve Growth Factor Mediates Signal Transduction ThroughtrkHomodimer Receptors”Neuron.(1992) vol. 9, pp. 1067-1079.
Johnson, et al. “Expression and Structure of the Human NGF Receptor”Cell(1986) vol. 47, pp. 545-554.
Kaplan, et al. “ThetrkProto-Oncogene Product: A Signal Transducing Receptor for Nerve Growth Factor”Science(1991) vol. 252, pp. 554-558.
Kaplan, et al. “Tyrosine Phosphorylation and Tyrosine Kinase Activity of thetrkProto-oncogene Product Induced by NGF”Nature(1991) vol. 350, pp. 158-160.
Klein, et al. “trkB, A Novel Tyrosine Protein Kinase Receptor Expressed During Mouse Neural Development”Embro. J.(1989) vol. 8(12), pp. 3701-3709.
Klein et al. “ThetrkProto-oncogene Encoes a Receptor for Nerve Growth Factor”Cell(1991) vol. 65. pp. 189-197.
Knusel, et al. “K-252 Compounds: Modulators of Neurotrophin Signal Transduction”J. of Neurochemisty(1992) vol. 59, pp. 1987.
Korsching, S. “The Neurotrophic Factor Concept: A Reexamination”Neorosci. (1993) vol. 13, pp. 2739-2748.
Lamballe, et al. “trkC, A New Member of thetrkFamily of Tyrosine Protein Kinases, is a Receptor for Neurotrophin-3”Cell(1991) vol. 66, pp. 967-979.
Levi-Montalcini, R. “The Nerve Growth Factor 35 Years Later”Science(1987) vol. 237, pp. 1154-1162.
Loeb, et al. “NGF and Other Growth Factors Induce an Association Between ERK1 and the NGF Receptor, gp 140prototrk”Neuron(1992) vol. 9, pp. 1053-1065.
Martin-Zanca, et al. “Molecular and Biochemical Characterization of the HumantrkProto-Oncogene”Mol. Cell. Biol.(1989) vol. 9, pp. 24-33.
Martin-Zanca, et al. “Expression of the trk Proto-Oncogene is Restricted to the Sensory Cranial and Spinal Ganglia of Neural Crest Origin in Mouse Development” GenesDev.(1990) vol. 4, pp. 683-694.
Meakin, et al. “Molecular Investigations on the High-Affinity Nerve Growth Factor Receptor”Neuron(1991) vol. 6, pp. 153-163.
Middlemas, et al. “trkB, a Neural Receptor Protein-Tyrsoine Kinase: Evidence for a Full-Length and Two Truncated Receptors”Mol. Cell. Biol.(1991) vol. 11, pp. 143-143.
Obermeirer, et al. “Tyrosine 785 is a Major Determinant of Trk- Substrate Interaction”Ebmbro. J.(1993) vol. 12, pp. 933-941.
Ohmichi, et al. “Nerve Growth Factor Binds to the 140 kdtrkProto-Oncogene Product and Stimulates its Association with thesrcHomology Domain of Phospholipase C y1”Biochem. Biophys. Res. Commun.(1991) vol. 179, pp. 217-223.
Ohmichi, et al. “Activation of Phosphatidylinositol-3 by Nerve Growth Factor Involves Indirect Coupling of thetrkProto-Oncogene withsrcHomology 2 Domains”Neuron(1992) vol. 9, pp. 769-777.
Persson, et al. “Role and Expression of Neurotrophins and thetrkFamily of Tyrosine Kinase Receptors in Neural Growth and Rescue After Injury”Current Opinion in Neurology and Neurosurgery(1993) vol. 6, p. 11.
Pulido, et al. “Dtrk, A Drosophila Gene Related to thetrkFamily of Neurotrophin Receptors, Encodes A Novel Class of Neural Cell Adhesion Molecule”Ebro(1992) vol. 11, pp. 391-404.
Radeke, et al. “Gene Transfer and Molecular Cloning of the Rat Nerve Growth Factor Receptor”Nature(1987) vol. 325, 593-597.
Radeke, et al. “Analytical Purification of the Slow, High Affinity NGF Receptor: Identification of a Novel 135 kd Polypeptide”Neuron(1991) vol. 7, pp. 141-150.
Rin
Austin LeeAnn R.
Clary Douglas O.
Reichardt Louis F.
Weskamp Gisela
Borden Paula A.
Bozicevic Field & Francis LLP
Gucker Stephen
Stucker Jeffrey
The Regents of the University of California
LandOfFree
Antibodies that mimic actions of neurotrophins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies that mimic actions of neurotrophins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies that mimic actions of neurotrophins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4024316